Trial intelligence / Profile preview

Hypertonic Saline vs. Mannitol for Elevated ICP

NCT01111682Phase 3Terminated

Sponsor
University of Cincinnati
Start
Apr 2010
Primary completion
Nov 2010
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

A Phase 3 trial of hypertonic saline in intracranial hypertension (IH), sponsored by University of Cincinnati. Started Apr 2010; status: terminated.

02

Drugs

hypertonic saline
03

Conditions

intracranial hypertension (IH)

Beyond the preview

Go deeper on NCT01111682.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01111682.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call